Stefan James is Professor of Cardiology at Uppsala University, Scientific Director of Uppsala Clinical Research Center and a senior Interventional Cardiologist at Uppsala University Hospital Sweden. He is the president of the Swedish society of Cardiology and a Fellow of the ESC. Professor James co-chaired the previous and current 2017 ESC guidelines for ST-elevation myocardial infarction, co-author of several of the recent European guidelines on ACS and revascularization.
Stefan James has served on executive steering committees for numerous international trials in cardiology. He has long served as the chairman of the SCAAR and a member of the steering committee of SWEDEHEART. He has pioneered the concept of registry based randomized clinical trials. His research has been published in over 400 peer-reviewed cardiology journals, and he is an associate editor of Circulation and an editorial board member for the EHJ and AHJ
Session :
Residual cardiovascular risk after an acute coronary syndrome: identifying, stratifying and managing patients at long term risk of atherothrombotic cardiovascular events (EBAC Accredited)
Speaker : S
James
(Uppsala,SE), DJ
Angiolillo
(Jacksonville,US), SJ
Nicholls
(Adelaide,AU), M
Bonaca
(Boston,US)
Session :
Residual cardiovascular risk after an acute coronary syndrome: identifying, stratifying and managing patients at long term risk of atherothrombotic cardiovascular events (EBAC Accredited)
Session :
Residual cardiovascular risk after an acute coronary syndrome: identifying, stratifying and managing patients at long term risk of atherothrombotic cardiovascular events (EBAC Accredited)
Session :
Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)
Speaker : P
Steg
(Paris,FR), DJ
Angiolillo
(Jacksonville,US), S
James
(Uppsala,SE), R
Mehran
(New York,US)
Session :
Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)
Session :
Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)
Session :
Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)
Speaker : R
Mehran
(New York,US), S
James
(Uppsala,SE)
Session :
Dual anti-platelet therapy in 2015 – Reviewing the evidence
Speaker : S
James
(Uppsala,SE)
Organised by The Sahlgrenska Academy - Goteborg University Course Director: Karl Swedberg Supported by an unrestricted educational grant from AstraZeneca
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease
